Related Experiment Video
Updated: Apr 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Proton therapy for head and neck cancer
J Nicholas Lukens1, Alexander Lin, Stephen M Hahn
1aDepartment of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania bDivision of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas, USA.
Proton therapy shows promise for head and neck cancer, potentially reducing side effects. Further research is needed to confirm benefits and guide patient selection for intensity-modulated proton therapy (IMPT) versus intensity-modulated radiotherapy.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Physics
Background:
- Proton therapy is under active investigation for head and neck cancers.
- Technological advancements and cost considerations drive research in this field.
Purpose of the Study:
- To review recent research in proton dosimetry for head and neck cancer.
- To evaluate the clinical benefits of proton therapy compared to other advanced radiotherapy techniques.
- To discuss safety and cost implications of proton therapy.
Main Methods:
- Analysis of recent dosimetric studies, particularly for intensity-modulated proton therapy (IMPT).
- Review of clinical studies assessing local control and morbidity.
- Examination of data in re-irradiation and oropharyngeal cancer settings.
Main Results:
- IMPT can reduce dose to critical structures in the head and neck, but carries risks of dose uncertainty.
- Proton therapy demonstrates potential for excellent local control and reduced morbidity near neurological structures.
- Promising data exists for re-irradiation and emerging data for IMPT in oropharyngeal cancer.
Conclusions:
- Proton therapy for head and neck cancer shows significant potential, requiring validation in randomized trials.
- Further evidence is necessary to determine optimal patient allocation between IMPT and intensity-modulated radiotherapy due to cost.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Treatment Resistant Cancers
Treatment Resistent Cancers
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies

